

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane organization (GO:0097090) | 7.62559894 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.82347466 |
| 3 | presynaptic membrane assembly (GO:0097105) | 6.14901953 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.39483849 |
| 5 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.27315973 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.13117179 |
| 7 | layer formation in cerebral cortex (GO:0021819) | 5.03168552 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.01262633 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.81932790 |
| 10 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.72285834 |
| 11 | vocalization behavior (GO:0071625) | 4.67091897 |
| 12 | glutamate secretion (GO:0014047) | 4.65952661 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.61624369 |
| 14 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.52914620 |
| 15 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.52914620 |
| 16 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.52914620 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.49865232 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 4.41441018 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.33345350 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.31619080 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.29788460 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.28008164 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.21146353 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.07624498 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.06224445 |
| 26 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.02445888 |
| 27 | exploration behavior (GO:0035640) | 4.00796556 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.00315807 |
| 29 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.97799719 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 3.94904709 |
| 31 | protein localization to synapse (GO:0035418) | 3.94801449 |
| 32 | neuron recognition (GO:0008038) | 3.93323634 |
| 33 | prepulse inhibition (GO:0060134) | 3.86261599 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.86175022 |
| 35 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.84226884 |
| 36 | protein K6-linked ubiquitination (GO:0085020) | 3.83548244 |
| 37 | neuronal action potential propagation (GO:0019227) | 3.78854173 |
| 38 | nucleobase catabolic process (GO:0046113) | 3.77705891 |
| 39 | regulation of synaptic vesicle transport (GO:1902803) | 3.77279499 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.76545988 |
| 41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.72867691 |
| 42 | L-amino acid import (GO:0043092) | 3.72056296 |
| 43 | transmission of nerve impulse (GO:0019226) | 3.69012890 |
| 44 | postsynaptic membrane organization (GO:0001941) | 3.68143510 |
| 45 | cellular potassium ion homeostasis (GO:0030007) | 3.65346333 |
| 46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.58935251 |
| 47 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.56386086 |
| 48 | dendrite morphogenesis (GO:0048813) | 3.55009269 |
| 49 | neuromuscular process controlling balance (GO:0050885) | 3.52465094 |
| 50 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.51667217 |
| 51 | cerebellar granule cell differentiation (GO:0021707) | 3.44600377 |
| 52 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.43612210 |
| 53 | sodium ion export (GO:0071436) | 3.42147813 |
| 54 | proline transport (GO:0015824) | 3.41885762 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.41113722 |
| 56 | positive regulation of synapse assembly (GO:0051965) | 3.37342552 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.37174100 |
| 58 | positive regulation of synapse maturation (GO:0090129) | 3.36030189 |
| 59 | axonal fasciculation (GO:0007413) | 3.34376013 |
| 60 | neurotransmitter transport (GO:0006836) | 3.33174477 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.32069860 |
| 62 | cell migration in hindbrain (GO:0021535) | 3.29346845 |
| 63 | behavioral fear response (GO:0001662) | 3.28441797 |
| 64 | behavioral defense response (GO:0002209) | 3.28441797 |
| 65 | neuronal ion channel clustering (GO:0045161) | 3.26887295 |
| 66 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25176201 |
| 67 | olfactory bulb development (GO:0021772) | 3.24792924 |
| 68 | amino acid import (GO:0043090) | 3.24457134 |
| 69 | long-term memory (GO:0007616) | 3.22209977 |
| 70 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.19881906 |
| 71 | vesicle transport along microtubule (GO:0047496) | 3.19627587 |
| 72 | synaptic vesicle endocytosis (GO:0048488) | 3.17872441 |
| 73 | positive regulation of dendrite morphogenesis (GO:0050775) | 3.17177918 |
| 74 | DNA double-strand break processing (GO:0000729) | 3.16734899 |
| 75 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15367841 |
| 76 | membrane hyperpolarization (GO:0060081) | 3.14003810 |
| 77 | activation of protein kinase A activity (GO:0034199) | 3.13532358 |
| 78 | regulation of synaptic plasticity (GO:0048167) | 3.12416656 |
| 79 | mating behavior (GO:0007617) | 3.12325966 |
| 80 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11833051 |
| 81 | positive regulation of membrane potential (GO:0045838) | 3.10867498 |
| 82 | serotonin metabolic process (GO:0042428) | 3.08346137 |
| 83 | membrane assembly (GO:0071709) | 3.07533312 |
| 84 | response to auditory stimulus (GO:0010996) | 3.06261870 |
| 85 | auditory behavior (GO:0031223) | 3.04907537 |
| 86 | regulation of neurotransmitter levels (GO:0001505) | 3.03698794 |
| 87 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.03565976 |
| 88 | glycine transport (GO:0015816) | 3.02958104 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.01440186 |
| 90 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.01370235 |
| 91 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.00217098 |
| 92 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.99848355 |
| 93 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.99406688 |
| 94 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.98591149 |
| 95 | adult walking behavior (GO:0007628) | 2.98546219 |
| 96 | C4-dicarboxylate transport (GO:0015740) | 2.98383917 |
| 97 | striatum development (GO:0021756) | 2.97280402 |
| 98 | fear response (GO:0042596) | 2.97104204 |
| 99 | organelle transport along microtubule (GO:0072384) | 2.96756553 |
| 100 | positive regulation of dendrite development (GO:1900006) | 2.94961053 |
| 101 | adaptation of signaling pathway (GO:0023058) | 2.94826268 |
| 102 | replication fork processing (GO:0031297) | 2.92956137 |
| 103 | dopamine receptor signaling pathway (GO:0007212) | 2.92754779 |
| 104 | histone H3-K9 demethylation (GO:0033169) | 2.92271611 |
| 105 | histone H3-K36 demethylation (GO:0070544) | 2.90118582 |
| 106 | clathrin coat assembly (GO:0048268) | 2.89589490 |
| 107 | mechanosensory behavior (GO:0007638) | 2.89395269 |
| 108 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.89069291 |
| 109 | nonmotile primary cilium assembly (GO:0035058) | 2.88400588 |
| 110 | regulation of dendritic spine development (GO:0060998) | 2.85333309 |
| 111 | neuromuscular process (GO:0050905) | 2.85006156 |
| 112 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.84577496 |
| 113 | behavioral response to nicotine (GO:0035095) | 2.83790404 |
| 114 | synapse assembly (GO:0007416) | 2.81594453 |
| 115 | membrane depolarization (GO:0051899) | 2.81575617 |
| 116 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.80705090 |
| 117 | regulation of dendrite morphogenesis (GO:0048814) | 2.79248248 |
| 118 | synapse organization (GO:0050808) | 2.79147295 |
| 119 | protein K11-linked deubiquitination (GO:0035871) | 2.79051682 |
| 120 | regulation of neurotransmitter secretion (GO:0046928) | 2.78544202 |
| 121 | regulation of collateral sprouting (GO:0048670) | 2.78413483 |
| 122 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.78255959 |
| 123 | retinal cone cell development (GO:0046549) | 2.76305358 |
| 124 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.74779627 |
| 125 | protein prenylation (GO:0018342) | 2.72826515 |
| 126 | prenylation (GO:0097354) | 2.72826515 |
| 127 | startle response (GO:0001964) | 2.70255652 |
| 128 | protein polyglutamylation (GO:0018095) | 2.69991584 |
| 129 | regulation of neurotransmitter uptake (GO:0051580) | 2.69388476 |
| 130 | neural tube formation (GO:0001841) | 2.68273740 |
| 131 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.67173843 |
| 132 | negative regulation of DNA recombination (GO:0045910) | 2.65486574 |
| 133 | negative regulation of membrane potential (GO:0045837) | 2.63125758 |
| 134 | negative regulation of dendrite development (GO:2000171) | 2.62821828 |
| 135 | primary amino compound metabolic process (GO:1901160) | 2.62271998 |
| 136 | inositol phosphate catabolic process (GO:0071545) | 2.61359194 |
| 137 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.61310768 |
| 138 | limb bud formation (GO:0060174) | 2.59578701 |
| 139 | prostate gland growth (GO:0060736) | 2.56004971 |
| 140 | reflex (GO:0060004) | 2.54369442 |
| 141 | fucose catabolic process (GO:0019317) | 2.53349554 |
| 142 | L-fucose metabolic process (GO:0042354) | 2.53349554 |
| 143 | L-fucose catabolic process (GO:0042355) | 2.53349554 |
| 144 | glycosphingolipid biosynthetic process (GO:0006688) | 2.51798482 |
| 145 | kidney morphogenesis (GO:0060993) | 2.51648470 |
| 146 | resolution of meiotic recombination intermediates (GO:0000712) | 2.50669986 |
| 147 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.49188207 |
| 148 | regulation of timing of cell differentiation (GO:0048505) | 2.47966334 |
| 149 | protein complex biogenesis (GO:0070271) | 2.47838241 |
| 150 | cytochrome complex assembly (GO:0017004) | 2.47461002 |
| 151 | neurotransmitter uptake (GO:0001504) | 2.46199219 |
| 152 | cell wall macromolecule catabolic process (GO:0016998) | 2.42367387 |
| 153 | platelet dense granule organization (GO:0060155) | 2.41608381 |
| 154 | response to pheromone (GO:0019236) | 2.39977992 |
| 155 | cell wall macromolecule metabolic process (GO:0044036) | 2.39896327 |
| 156 | protein localization to cilium (GO:0061512) | 2.38999099 |
| 157 | respiratory chain complex IV assembly (GO:0008535) | 2.36629515 |
| 158 | glial cell proliferation (GO:0014009) | 2.34707262 |
| 159 | sympathetic nervous system development (GO:0048485) | 2.33201643 |
| 160 | brain morphogenesis (GO:0048854) | 2.32987346 |
| 161 | positive regulation of mRNA processing (GO:0050685) | 2.32871010 |
| 162 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.32770545 |
| 163 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.30460808 |
| 164 | anterograde axon cargo transport (GO:0008089) | 2.30450351 |
| 165 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.29743779 |
| 166 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.29743779 |
| 167 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.29107627 |
| 168 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.27518529 |
| 169 | regulation of development, heterochronic (GO:0040034) | 2.26212898 |
| 170 | limb development (GO:0060173) | 2.26009756 |
| 171 | appendage development (GO:0048736) | 2.26009756 |
| 172 | anterograde synaptic vesicle transport (GO:0048490) | 2.25977128 |
| 173 | central nervous system neuron axonogenesis (GO:0021955) | 2.23914542 |
| 174 | righting reflex (GO:0060013) | 2.23483774 |
| 175 | sulfation (GO:0051923) | 2.23044219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.78881283 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61436116 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.88522359 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.77628477 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.74354160 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.73234947 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.67939093 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.65733371 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.61298723 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.60196285 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50581479 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50581479 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43805805 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.26835954 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25293562 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25008036 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.20709745 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.18250673 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.17173788 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.16630252 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.15279695 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.15154526 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13806462 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07757836 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 2.04877608 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04195958 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.99028812 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98386762 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95589510 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93754468 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93424468 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88396502 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86403567 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.84497488 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79129541 |
| 36 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74510358 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69863572 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68823859 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68348130 |
| 40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.67140427 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.66930480 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66450962 |
| 43 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65354646 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.63273049 |
| 45 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.56415208 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55233139 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52671720 |
| 48 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52671720 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52160814 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52152728 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48691574 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43233154 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42723927 |
| 54 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41412963 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41368523 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40212542 |
| 57 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39756098 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38926784 |
| 59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38693011 |
| 60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38588066 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38242987 |
| 62 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38049273 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37763884 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.37454533 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36447660 |
| 66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36355464 |
| 67 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36213612 |
| 68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.36155658 |
| 69 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.35770566 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34010870 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32875311 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.32858923 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32323483 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29949627 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28851966 |
| 76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28467938 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28386967 |
| 78 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.27859292 |
| 79 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27599276 |
| 80 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.26861845 |
| 81 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24200106 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23596043 |
| 83 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22890676 |
| 84 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.22586893 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21948294 |
| 86 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.21177790 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21008270 |
| 88 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20262287 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19721530 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19510243 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18678632 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.18629354 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18405793 |
| 94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18398511 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17950745 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17812769 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17332397 |
| 98 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17082092 |
| 99 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.16750192 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16637249 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16096297 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15900549 |
| 103 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15777039 |
| 104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14853733 |
| 105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13606301 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12936848 |
| 107 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12829631 |
| 108 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11803241 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11498998 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11498998 |
| 111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10288118 |
| 112 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10049607 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09593433 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09131906 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08731736 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.08337597 |
| 117 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07963937 |
| 118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07419198 |
| 119 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07282576 |
| 120 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06520178 |
| 121 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05983248 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05813272 |
| 123 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05281468 |
| 124 | JUN_21703547_ChIP-Seq_K562_Human | 1.05107726 |
| 125 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04989794 |
| 126 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.04508463 |
| 127 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03953064 |
| 128 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03586811 |
| 129 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03406581 |
| 130 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.03231062 |
| 131 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01934172 |
| 132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01243093 |
| 133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01076856 |
| 134 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00920918 |
| 135 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00624368 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00528672 |
| 137 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00345365 |
| 138 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99229902 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99092812 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98872825 |
| 141 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97888925 |
| 142 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97694249 |
| 143 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96787075 |
| 144 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96441044 |
| 145 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.96267262 |
| 146 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96214738 |
| 147 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94899636 |
| 148 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94067963 |
| 149 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93727196 |
| 150 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93727196 |
| 151 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93593094 |
| 152 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.93491539 |
| 153 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93370836 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92617455 |
| 155 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92047974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.14552276 |
| 2 | MP0003880_abnormal_central_pattern | 4.32236258 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.03402387 |
| 4 | MP0004270_analgesia | 3.43513231 |
| 5 | MP0009745_abnormal_behavioral_response | 3.24708144 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.18993874 |
| 7 | MP0002064_seizures | 3.10521740 |
| 8 | MP0009046_muscle_twitch | 3.06223720 |
| 9 | MP0003646_muscle_fatigue | 2.94307110 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.60506141 |
| 11 | MP0002102_abnormal_ear_morphology | 2.46394272 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.43912403 |
| 13 | MP0001486_abnormal_startle_reflex | 2.40898580 |
| 14 | MP0001440_abnormal_grooming_behavior | 2.34532824 |
| 15 | MP0002272_abnormal_nervous_system | 2.27699779 |
| 16 | MP0000778_abnormal_nervous_system | 2.21321468 |
| 17 | MP0003303_peritoneal_inflammation | 2.20730661 |
| 18 | MP0002822_catalepsy | 2.17473771 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.15307375 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.13614088 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.12393418 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.04987748 |
| 23 | MP0003329_amyloid_beta_deposits | 2.02835875 |
| 24 | MP0000372_irregular_coat_pigmentation | 1.96601440 |
| 25 | MP0003195_calcinosis | 1.90966211 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.89749944 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.89709810 |
| 28 | MP0004885_abnormal_endolymph | 1.88971042 |
| 29 | MP0008569_lethality_at_weaning | 1.85783323 |
| 30 | MP0005174_abnormal_tail_pigmentation | 1.83550073 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.83395490 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.82416233 |
| 33 | MP0001970_abnormal_pain_threshold | 1.77228197 |
| 34 | MP0005171_absent_coat_pigmentation | 1.76561467 |
| 35 | MP0000955_abnormal_spinal_cord | 1.76542134 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.76300609 |
| 37 | MP0005248_abnormal_Harderian_gland | 1.73774219 |
| 38 | MP0002184_abnormal_innervation | 1.71507398 |
| 39 | MP0001188_hyperpigmentation | 1.69933467 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.67977030 |
| 41 | MP0004924_abnormal_behavior | 1.67405481 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.67405481 |
| 43 | MP0003136_yellow_coat_color | 1.65795962 |
| 44 | MP0008058_abnormal_DNA_repair | 1.62292731 |
| 45 | MP0004858_abnormal_nervous_system | 1.60828721 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.53372883 |
| 47 | MP0005253_abnormal_eye_physiology | 1.52973825 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.47611125 |
| 49 | MP0002751_abnormal_autonomic_nervous | 1.45216715 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.44398181 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.43803167 |
| 52 | MP0002736_abnormal_nociception_after | 1.42852059 |
| 53 | MP0002938_white_spotting | 1.42232410 |
| 54 | MP0000516_abnormal_urinary_system | 1.41147245 |
| 55 | MP0005367_renal/urinary_system_phenotyp | 1.41147245 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.38601119 |
| 57 | MP0002152_abnormal_brain_morphology | 1.38239275 |
| 58 | MP0004133_heterotaxia | 1.37493092 |
| 59 | MP0003633_abnormal_nervous_system | 1.36865294 |
| 60 | MP0000920_abnormal_myelination | 1.33678084 |
| 61 | MP0004130_abnormal_muscle_cell | 1.33473961 |
| 62 | MP0003690_abnormal_glial_cell | 1.31262028 |
| 63 | MP0003122_maternal_imprinting | 1.29489017 |
| 64 | MP0003787_abnormal_imprinting | 1.23000062 |
| 65 | MP0003631_nervous_system_phenotype | 1.22151442 |
| 66 | MP0003634_abnormal_glial_cell | 1.18074580 |
| 67 | MP0005187_abnormal_penis_morphology | 1.15838991 |
| 68 | MP0003632_abnormal_nervous_system | 1.14503490 |
| 69 | MP0008057_abnormal_DNA_replication | 1.10986089 |
| 70 | MP0004142_abnormal_muscle_tone | 1.10830644 |
| 71 | MP0003011_delayed_dark_adaptation | 1.09563386 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.07039363 |
| 73 | MP0001529_abnormal_vocalization | 1.06708716 |
| 74 | MP0006276_abnormal_autonomic_nervous | 1.05406710 |
| 75 | MP0000427_abnormal_hair_cycle | 1.05392247 |
| 76 | MP0002095_abnormal_skin_pigmentation | 1.05074635 |
| 77 | MP0001986_abnormal_taste_sensitivity | 1.04974362 |
| 78 | MP0004742_abnormal_vestibular_system | 1.04829506 |
| 79 | MP0002229_neurodegeneration | 0.99968977 |
| 80 | MP0000747_muscle_weakness | 0.98891952 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.98651888 |
| 82 | MP0003861_abnormal_nervous_system | 0.98366326 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.97989397 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 0.96832496 |
| 85 | MP0004233_abnormal_muscle_weight | 0.96029440 |
| 86 | MP0000604_amyloidosis | 0.95979743 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 0.93219761 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.93001800 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.91759232 |
| 90 | MP0001324_abnormal_eye_pigmentation | 0.91465804 |
| 91 | MP0001177_atelectasis | 0.91173930 |
| 92 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90670257 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.89540873 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.89272586 |
| 95 | MP0005408_hypopigmentation | 0.89136639 |
| 96 | MP0001502_abnormal_circadian_rhythm | 0.88385997 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.88182128 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.87760076 |
| 99 | MP0005499_abnormal_olfactory_system | 0.87760076 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.87589856 |
| 101 | MP0006292_abnormal_olfactory_placode | 0.86779377 |
| 102 | MP0002928_abnormal_bile_duct | 0.86189472 |
| 103 | MP0004381_abnormal_hair_follicle | 0.83366125 |
| 104 | MP0001984_abnormal_olfaction | 0.83237029 |
| 105 | MP0003718_maternal_effect | 0.82282688 |
| 106 | MP0010094_abnormal_chromosome_stability | 0.81434768 |
| 107 | MP0008789_abnormal_olfactory_epithelium | 0.80852616 |
| 108 | MP0008872_abnormal_physiological_respon | 0.78409456 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 0.77723981 |
| 110 | MP0003724_increased_susceptibility_to | 0.77291865 |
| 111 | MP0003119_abnormal_digestive_system | 0.77078728 |
| 112 | MP0003123_paternal_imprinting | 0.76784491 |
| 113 | MP0000026_abnormal_inner_ear | 0.76359120 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.74342347 |
| 115 | MP0008961_abnormal_basal_metabolism | 0.73884303 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.73871017 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.73639507 |
| 118 | MP0001905_abnormal_dopamine_level | 0.71024311 |
| 119 | MP0003879_abnormal_hair_cell | 0.70982542 |
| 120 | MP0003121_genomic_imprinting | 0.70089438 |
| 121 | MP0010769_abnormal_survival | 0.68381395 |
| 122 | MP0010770_preweaning_lethality | 0.67978998 |
| 123 | MP0002082_postnatal_lethality | 0.67978998 |
| 124 | MP0005551_abnormal_eye_electrophysiolog | 0.67173044 |
| 125 | MP0003385_abnormal_body_wall | 0.66930610 |
| 126 | MP0008877_abnormal_DNA_methylation | 0.65850239 |
| 127 | MP0001485_abnormal_pinna_reflex | 0.65021868 |
| 128 | MP0005409_darkened_coat_color | 0.64846617 |
| 129 | MP0010768_mortality/aging | 0.64716592 |
| 130 | MP0008874_decreased_physiological_sensi | 0.64256386 |
| 131 | MP0002090_abnormal_vision | 0.63735270 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.61622174 |
| 133 | MP0005535_abnormal_body_temperature | 0.61543577 |
| 134 | MP0001943_abnormal_respiration | 0.60584471 |
| 135 | MP0009379_abnormal_foot_pigmentation | 0.60262252 |
| 136 | MP0001963_abnormal_hearing_physiology | 0.59169027 |
| 137 | MP0004043_abnormal_pH_regulation | 0.58658386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.78216786 |
| 2 | Myokymia (HP:0002411) | 4.73799751 |
| 3 | Focal seizures (HP:0007359) | 4.44349667 |
| 4 | Ankle clonus (HP:0011448) | 3.90535033 |
| 5 | Visual hallucinations (HP:0002367) | 3.85077807 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 3.57726653 |
| 7 | Cutaneous melanoma (HP:0012056) | 3.49130039 |
| 8 | Scanning speech (HP:0002168) | 3.46223399 |
| 9 | Absent speech (HP:0001344) | 3.42515826 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.32565714 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.27705666 |
| 12 | Retinal atrophy (HP:0001105) | 3.27132991 |
| 13 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.19481859 |
| 14 | Buphthalmos (HP:0000557) | 3.14555812 |
| 15 | Type II lissencephaly (HP:0007260) | 3.13413908 |
| 16 | Methylmalonic acidemia (HP:0002912) | 3.06042987 |
| 17 | Neoplasm of the adrenal cortex (HP:0100641) | 3.04513602 |
| 18 | Methylmalonic aciduria (HP:0012120) | 3.04133111 |
| 19 | Termporal pattern (HP:0011008) | 3.02521214 |
| 20 | Insidious onset (HP:0003587) | 3.02521214 |
| 21 | Retinal dysplasia (HP:0007973) | 3.02018282 |
| 22 | Cerebral inclusion bodies (HP:0100314) | 2.98038844 |
| 23 | Hepatoblastoma (HP:0002884) | 2.97714313 |
| 24 | Abnormality of the labia minora (HP:0012880) | 2.93649439 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.93241491 |
| 26 | Neurofibrillary tangles (HP:0002185) | 2.92199929 |
| 27 | Urinary urgency (HP:0000012) | 2.91756923 |
| 28 | Action tremor (HP:0002345) | 2.91508311 |
| 29 | Astrocytoma (HP:0009592) | 2.90047970 |
| 30 | Abnormality of the astrocytes (HP:0100707) | 2.90047970 |
| 31 | Spastic gait (HP:0002064) | 2.89561478 |
| 32 | Postural instability (HP:0002172) | 2.84963286 |
| 33 | Dialeptic seizures (HP:0011146) | 2.84876233 |
| 34 | Pancreatic cysts (HP:0001737) | 2.80952717 |
| 35 | Neoplasm of the adrenal gland (HP:0100631) | 2.80411348 |
| 36 | Absence seizures (HP:0002121) | 2.73990567 |
| 37 | Genetic anticipation (HP:0003743) | 2.72856294 |
| 38 | Meningioma (HP:0002858) | 2.71966372 |
| 39 | Cerebellar dysplasia (HP:0007033) | 2.71593394 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 2.71328669 |
| 41 | Inability to walk (HP:0002540) | 2.70120996 |
| 42 | Abnormality of the corticospinal tract (HP:0002492) | 2.66263829 |
| 43 | Spastic tetraparesis (HP:0001285) | 2.64917269 |
| 44 | Atonic seizures (HP:0010819) | 2.63760657 |
| 45 | Hypothermia (HP:0002045) | 2.63132406 |
| 46 | Excessive salivation (HP:0003781) | 2.62907784 |
| 47 | Drooling (HP:0002307) | 2.62907784 |
| 48 | Febrile seizures (HP:0002373) | 2.62764861 |
| 49 | Broad-based gait (HP:0002136) | 2.62168529 |
| 50 | Mutism (HP:0002300) | 2.62144236 |
| 51 | Truncal ataxia (HP:0002078) | 2.60026835 |
| 52 | Abnormal eating behavior (HP:0100738) | 2.59564936 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.57476526 |
| 54 | Medial flaring of the eyebrow (HP:0010747) | 2.56761809 |
| 55 | Ependymoma (HP:0002888) | 2.55241656 |
| 56 | Megalencephaly (HP:0001355) | 2.53938725 |
| 57 | Dysmetria (HP:0001310) | 2.52621813 |
| 58 | Gaze-evoked nystagmus (HP:0000640) | 2.51059267 |
| 59 | Subacute progressive viral hepatitis (HP:0006572) | 2.50952224 |
| 60 | Depression (HP:0000716) | 2.50539032 |
| 61 | Pancreatic fibrosis (HP:0100732) | 2.49808322 |
| 62 | True hermaphroditism (HP:0010459) | 2.49272313 |
| 63 | Intention tremor (HP:0002080) | 2.47561309 |
| 64 | Tented upper lip vermilion (HP:0010804) | 2.47102503 |
| 65 | Anterior segment dysgenesis (HP:0007700) | 2.46234945 |
| 66 | Gait imbalance (HP:0002141) | 2.45885770 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 2.44887964 |
| 68 | Papilledema (HP:0001085) | 2.43811426 |
| 69 | Stomach cancer (HP:0012126) | 2.42710599 |
| 70 | Dysmetric saccades (HP:0000641) | 2.41037475 |
| 71 | Amyotrophic lateral sclerosis (HP:0007354) | 2.40919544 |
| 72 | Poor eye contact (HP:0000817) | 2.40604796 |
| 73 | Impaired social interactions (HP:0000735) | 2.39566741 |
| 74 | Abnormal social behavior (HP:0012433) | 2.39566741 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.39055266 |
| 76 | Abnormality of the lower motor neuron (HP:0002366) | 2.38595168 |
| 77 | Agnosia (HP:0010524) | 2.38484113 |
| 78 | Bradykinesia (HP:0002067) | 2.34008437 |
| 79 | Genital tract atresia (HP:0001827) | 2.33374700 |
| 80 | Abolished electroretinogram (ERG) (HP:0000550) | 2.29956173 |
| 81 | Congenital primary aphakia (HP:0007707) | 2.27468286 |
| 82 | Insomnia (HP:0100785) | 2.25841446 |
| 83 | Vaginal atresia (HP:0000148) | 2.25012633 |
| 84 | Clonus (HP:0002169) | 2.22640228 |
| 85 | Volvulus (HP:0002580) | 2.21939861 |
| 86 | Glioma (HP:0009733) | 2.20486994 |
| 87 | Impaired smooth pursuit (HP:0007772) | 2.20079031 |
| 88 | Hyperglycinemia (HP:0002154) | 2.19683919 |
| 89 | Hemiparesis (HP:0001269) | 2.19387652 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18353919 |
| 91 | Diplopia (HP:0000651) | 2.17172427 |
| 92 | Abnormality of binocular vision (HP:0011514) | 2.17172427 |
| 93 | Abnormality of midbrain morphology (HP:0002418) | 2.13834925 |
| 94 | Molar tooth sign on MRI (HP:0002419) | 2.13834925 |
| 95 | Hypoplasia of the brainstem (HP:0002365) | 2.12944813 |
| 96 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.12944813 |
| 97 | Pointed chin (HP:0000307) | 2.12374894 |
| 98 | Progressive inability to walk (HP:0002505) | 2.10555601 |
| 99 | Colon cancer (HP:0003003) | 2.10549991 |
| 100 | Intellectual disability, profound (HP:0002187) | 2.07890104 |
| 101 | Intellectual disability, moderate (HP:0002342) | 2.07264837 |
| 102 | Congenital sensorineural hearing impairment (HP:0008527) | 2.06616599 |
| 103 | Impaired vibratory sensation (HP:0002495) | 2.03543329 |
| 104 | Nephronophthisis (HP:0000090) | 2.02660282 |
| 105 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.02611944 |
| 106 | Megalocornea (HP:0000485) | 2.02365868 |
| 107 | Attenuation of retinal blood vessels (HP:0007843) | 2.01596064 |
| 108 | Polyphagia (HP:0002591) | 2.00031332 |
| 109 | Pheochromocytoma (HP:0002666) | 1.99664572 |
| 110 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98819129 |
| 111 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98819129 |
| 112 | Pendular nystagmus (HP:0012043) | 1.98552375 |
| 113 | Ankyloglossia (HP:0010296) | 1.98270735 |
| 114 | Intestinal atresia (HP:0011100) | 1.94081785 |
| 115 | Poor coordination (HP:0002370) | 1.91996626 |
| 116 | Difficulty climbing stairs (HP:0003551) | 1.91953801 |
| 117 | Chronic hepatic failure (HP:0100626) | 1.91674662 |
| 118 | Amblyopia (HP:0000646) | 1.91417055 |
| 119 | Epileptiform EEG discharges (HP:0011182) | 1.90918038 |
| 120 | EEG with generalized epileptiform discharges (HP:0011198) | 1.90831664 |
| 121 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.90786403 |
| 122 | Hypoplasia of the fovea (HP:0007750) | 1.90786403 |
| 123 | Papillary thyroid carcinoma (HP:0002895) | 1.90464291 |
| 124 | Abnormality of the renal cortex (HP:0011035) | 1.89983100 |
| 125 | Open mouth (HP:0000194) | 1.89702674 |
| 126 | Hyperventilation (HP:0002883) | 1.89491335 |
| 127 | Inappropriate behavior (HP:0000719) | 1.88824570 |
| 128 | Specific learning disability (HP:0001328) | 1.88399015 |
| 129 | Abnormality of the parathyroid morphology (HP:0011766) | 1.88006341 |
| 130 | Hamartoma of the eye (HP:0010568) | 1.87978104 |
| 131 | Overriding aorta (HP:0002623) | 1.87651374 |
| 132 | Agitation (HP:0000713) | 1.87542294 |
| 133 | Pachygyria (HP:0001302) | 1.87362625 |
| 134 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.87333839 |
| 135 | Short 1st metacarpal (HP:0010034) | 1.87333839 |
| 136 | Hypsarrhythmia (HP:0002521) | 1.87058637 |
| 137 | Limb dystonia (HP:0002451) | 1.85939894 |
| 138 | Lissencephaly (HP:0001339) | 1.84270885 |
| 139 | Apathy (HP:0000741) | 1.83996355 |
| 140 | Spinal rigidity (HP:0003306) | 1.83662276 |
| 141 | Abnormality of chromosome stability (HP:0003220) | 1.83026324 |
| 142 | Stereotypic behavior (HP:0000733) | 1.82734765 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.81693915 |
| 144 | Decreased central vision (HP:0007663) | 1.81609740 |
| 145 | Hemiplegia (HP:0002301) | 1.81424478 |
| 146 | Abnormality of the renal medulla (HP:0100957) | 1.80984591 |
| 147 | Abnormality of vitamin B metabolism (HP:0004340) | 1.79216279 |
| 148 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.79164942 |
| 149 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78560271 |
| 150 | Renal hypoplasia (HP:0000089) | 1.77687591 |
| 151 | Congenital stationary night blindness (HP:0007642) | 1.76006027 |
| 152 | Protruding tongue (HP:0010808) | 1.75794564 |
| 153 | Neuroendocrine neoplasm (HP:0100634) | 1.75067989 |
| 154 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.74019570 |
| 155 | Neoplasm of the oral cavity (HP:0100649) | 1.73873182 |
| 156 | Astigmatism (HP:0000483) | 1.73803154 |
| 157 | Medulloblastoma (HP:0002885) | 1.70995889 |
| 158 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70550986 |
| 159 | Progressive macrocephaly (HP:0004481) | 1.69051196 |
| 160 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.68654151 |
| 161 | Benign neoplasm of the central nervous system (HP:0100835) | 1.68554990 |
| 162 | Optic nerve hypoplasia (HP:0000609) | 1.67350406 |
| 163 | Abnormality of the fovea (HP:0000493) | 1.66897674 |
| 164 | Thyroid carcinoma (HP:0002890) | 1.66055632 |
| 165 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.65591625 |
| 166 | Abnormal hair whorl (HP:0010721) | 1.65397277 |
| 167 | Ketoacidosis (HP:0001993) | 1.61959904 |
| 168 | Ectopic kidney (HP:0000086) | 1.61853909 |
| 169 | Goiter (HP:0000853) | 1.61348953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.34294196 |
| 2 | MARK1 | 4.24708806 |
| 3 | PNCK | 3.63177443 |
| 4 | NTRK3 | 3.39415609 |
| 5 | EPHA4 | 3.29800798 |
| 6 | MAP3K9 | 3.26789523 |
| 7 | MINK1 | 2.66141681 |
| 8 | NTRK2 | 2.51296581 |
| 9 | TRIM28 | 2.47063197 |
| 10 | MAP3K4 | 2.43220155 |
| 11 | PAK6 | 2.41097583 |
| 12 | MAP4K2 | 2.13344727 |
| 13 | BMPR1B | 2.06570329 |
| 14 | KSR2 | 2.02478312 |
| 15 | KSR1 | 2.00870396 |
| 16 | FES | 1.99121861 |
| 17 | CAMK1G | 1.96839940 |
| 18 | NUAK1 | 1.86418201 |
| 19 | NTRK1 | 1.80283115 |
| 20 | CSNK1G2 | 1.72962168 |
| 21 | DAPK2 | 1.68232368 |
| 22 | CAMKK1 | 1.66129670 |
| 23 | TYRO3 | 1.60254936 |
| 24 | SIK2 | 1.58878624 |
| 25 | ACVR1B | 1.58363203 |
| 26 | CSNK1A1L | 1.58054410 |
| 27 | MKNK2 | 1.56371608 |
| 28 | PRKD3 | 1.51062397 |
| 29 | CSNK1G3 | 1.48982099 |
| 30 | PINK1 | 1.48506876 |
| 31 | ZAK | 1.45095175 |
| 32 | UHMK1 | 1.44373248 |
| 33 | ALK | 1.42678314 |
| 34 | CDK5 | 1.42217252 |
| 35 | TSSK6 | 1.41364215 |
| 36 | PLK3 | 1.41241155 |
| 37 | MAP2K4 | 1.40241417 |
| 38 | MAP2K7 | 1.34153357 |
| 39 | CASK | 1.29750270 |
| 40 | CCNB1 | 1.29162320 |
| 41 | CAMKK2 | 1.24247281 |
| 42 | WNK1 | 1.22087729 |
| 43 | SCYL2 | 1.19521126 |
| 44 | DYRK2 | 1.18234959 |
| 45 | MKNK1 | 1.16165300 |
| 46 | LATS2 | 1.13774911 |
| 47 | CSNK1G1 | 1.11672388 |
| 48 | SRPK1 | 1.10453130 |
| 49 | PRKCG | 1.08725313 |
| 50 | GRK1 | 1.08342774 |
| 51 | SGK223 | 1.07273049 |
| 52 | SGK494 | 1.07273049 |
| 53 | MST4 | 1.07174861 |
| 54 | PRPF4B | 1.07059925 |
| 55 | YES1 | 1.03945147 |
| 56 | PHKG1 | 1.02213682 |
| 57 | PHKG2 | 1.02213682 |
| 58 | EPHA3 | 0.99213104 |
| 59 | MAP3K2 | 0.98721460 |
| 60 | TAOK3 | 0.98536204 |
| 61 | PLK2 | 0.98410598 |
| 62 | RIPK4 | 0.96839759 |
| 63 | MAPK13 | 0.95480333 |
| 64 | ICK | 0.92693339 |
| 65 | PLK4 | 0.91710790 |
| 66 | OXSR1 | 0.90552764 |
| 67 | STK38 | 0.89687317 |
| 68 | ADRBK2 | 0.88059496 |
| 69 | SGK3 | 0.86913695 |
| 70 | CDK18 | 0.85966934 |
| 71 | MARK2 | 0.85294921 |
| 72 | CDK14 | 0.85114816 |
| 73 | RET | 0.85084115 |
| 74 | STK11 | 0.84570894 |
| 75 | CDK15 | 0.83711121 |
| 76 | SGK2 | 0.82344061 |
| 77 | PRKCE | 0.81708707 |
| 78 | INSRR | 0.81708459 |
| 79 | FER | 0.81431335 |
| 80 | STK39 | 0.78467382 |
| 81 | DAPK1 | 0.77914647 |
| 82 | RIPK1 | 0.77633273 |
| 83 | PAK3 | 0.74534743 |
| 84 | CAMK1 | 0.74410166 |
| 85 | SGK1 | 0.73522114 |
| 86 | CDK11A | 0.70845166 |
| 87 | PRKCH | 0.70662751 |
| 88 | RAF1 | 0.69007282 |
| 89 | ARAF | 0.68670271 |
| 90 | DYRK1A | 0.68459403 |
| 91 | FGFR2 | 0.66242458 |
| 92 | STK38L | 0.65580421 |
| 93 | CAMK2A | 0.65425361 |
| 94 | PDK2 | 0.63577147 |
| 95 | OBSCN | 0.62136783 |
| 96 | CDK19 | 0.61433889 |
| 97 | PLK1 | 0.60651847 |
| 98 | PRKCZ | 0.59855429 |
| 99 | DYRK3 | 0.59594049 |
| 100 | CAMK2B | 0.58659432 |
| 101 | GRK5 | 0.58358709 |
| 102 | CAMK1D | 0.58057258 |
| 103 | MAP3K12 | 0.57660457 |
| 104 | WNK3 | 0.57596384 |
| 105 | ADRBK1 | 0.57050402 |
| 106 | SIK3 | 0.56789363 |
| 107 | NEK1 | 0.56246544 |
| 108 | CSNK1D | 0.55315059 |
| 109 | RPS6KA3 | 0.54329020 |
| 110 | MAP3K7 | 0.54228218 |
| 111 | TNK2 | 0.53706179 |
| 112 | TNIK | 0.53684229 |
| 113 | CAMK2G | 0.53069614 |
| 114 | FGR | 0.53002224 |
| 115 | BUB1 | 0.52434528 |
| 116 | MAPK10 | 0.51211446 |
| 117 | EIF2AK3 | 0.51171699 |
| 118 | FYN | 0.50863287 |
| 119 | BRSK2 | 0.50705940 |
| 120 | ERBB3 | 0.50245895 |
| 121 | BCKDK | 0.49766400 |
| 122 | CSNK1E | 0.48577694 |
| 123 | MARK3 | 0.48220620 |
| 124 | EIF2AK1 | 0.48068165 |
| 125 | FGFR1 | 0.46845562 |
| 126 | CAMK4 | 0.46624505 |
| 127 | CSNK1A1 | 0.45286590 |
| 128 | WNK4 | 0.45273401 |
| 129 | PDGFRA | 0.44697446 |
| 130 | ATR | 0.43853110 |
| 131 | LMTK2 | 0.43549990 |
| 132 | ERBB2 | 0.43361273 |
| 133 | BCR | 0.42858895 |
| 134 | ROCK2 | 0.42459543 |
| 135 | TAOK1 | 0.40822852 |
| 136 | PDK4 | 0.40413830 |
| 137 | PDK3 | 0.40413830 |
| 138 | PDPK1 | 0.38655467 |
| 139 | WEE1 | 0.38542754 |
| 140 | PDK1 | 0.38261284 |
| 141 | MAPK8 | 0.38010555 |
| 142 | GSK3B | 0.37183450 |
| 143 | ATM | 0.37179583 |
| 144 | PKN1 | 0.36862754 |
| 145 | NEK6 | 0.36774252 |
| 146 | PRKACB | 0.35933771 |
| 147 | EIF2AK2 | 0.34156943 |
| 148 | CDC7 | 0.33727427 |
| 149 | EGFR | 0.33106652 |
| 150 | PRKACA | 0.30908200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.42032060 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.87567309 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.49376871 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47218331 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46957214 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45804234 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34276942 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.26308792 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.22355149 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.21770728 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.19795791 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.16268890 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.12143935 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11441299 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.10550150 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09835424 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 2.02193632 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.97817081 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.95070104 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.89964669 |
| 21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86965929 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.84771241 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81393034 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79909035 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78428164 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.73771932 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.72109128 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70354904 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.65818630 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60749670 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.60474346 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.57014518 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54511827 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54464519 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51690969 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.48843130 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46911000 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41893697 |
| 39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39130300 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.38803847 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37792138 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.37611702 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.37023224 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.36560492 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 1.33143378 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28863595 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.28716143 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.28379736 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26628853 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.25584541 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 1.24136434 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.23360132 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.23265090 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22123597 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21741747 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20022621 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 1.18937850 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17713179 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17393519 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16294566 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15959795 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.14336646 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13521934 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12564926 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12510346 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11818614 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 1.08567202 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05199932 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03873190 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03590745 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01817954 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01291692 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98443226 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.97220952 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96927458 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95696315 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89145808 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87199666 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87103048 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86942645 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.86115388 |
| 82 | Mismatch repair_Homo sapiens_hsa03430 | 0.83782701 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81951655 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81165679 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80221900 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78752274 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78509292 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78288127 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77017077 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75978920 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74650832 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74144612 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73525562 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71591382 |
| 95 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71527149 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71401493 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70039031 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.69316662 |
| 99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.68909503 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68756132 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68745371 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68500067 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67845313 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.67745369 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.64816471 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64356225 |
| 107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63542383 |
| 108 | Base excision repair_Homo sapiens_hsa03410 | 0.62947716 |
| 109 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62516851 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60952972 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58883462 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57615028 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56018311 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55990615 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55364902 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54756781 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53778744 |
| 118 | Phototransduction_Homo sapiens_hsa04744 | 0.53369642 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53305508 |
| 120 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53237913 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52192608 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52060024 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51672410 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50830739 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50687396 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50488274 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50339860 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50003593 |
| 129 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49406030 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49362369 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48881655 |
| 132 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48257683 |
| 133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47115241 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46851750 |
| 135 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46588170 |
| 136 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46521377 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46320035 |
| 138 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46275023 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46231835 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45552135 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.43532886 |
| 142 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43383000 |
| 143 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43061338 |
| 144 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42686724 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.42350515 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.41384935 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40905002 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40797512 |
| 149 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38660824 |
| 150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38658682 |
| 151 | Melanoma_Homo sapiens_hsa05218 | 0.38169149 |
| 152 | Purine metabolism_Homo sapiens_hsa00230 | 0.37408430 |
| 153 | Lysine degradation_Homo sapiens_hsa00310 | 0.37213049 |
| 154 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37134433 |
| 155 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34073926 |
| 156 | ABC transporters_Homo sapiens_hsa02010 | 0.33390223 |
| 157 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33181772 |

